Novel nonquaternary reactivators showing reactivation efficiency for soman-inhibited human acetylcholinesterase. 2016

Zhao Wei, and Yan-Qin Liu, and Yong-An Wang, and Wan-Hua Li, and Xin-Bo Zhou, and Jian Zhao, and Chun-Qian Huang, and Xing-Zhou Li, and Jia Liu, and Zhi-Bing Zheng, and Song Li
Laboratory of Computer-Aided Drug Design & Discovery, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China.

Soman is a highly toxic nerve agent with strong inhibition of acetylcholinesterase (AChE), but of the few reactivators showing antidotal efficiency for soman-inhibited AChE presently are all permanently charged cationic oximes with poor penetration of the blood-brain barrier. To overcome this problem, uncharged reactivators have been designed and synthesized, but few of them were efficient for treating soman poisoning. Herein, we used a dual site biding strategy to develop more efficient uncharged reactivators. The ortho-hydroxylbenzaldoximes were chosen as reactivation ligands of AChE to prevent the secondary poisoning of AChE, and simple aromatic groups were used as peripheral site ligands of AChE, which were linked to the oximes in a similar way as that found in the reactivator HI-6. The in vitro experiment demonstrated that some of the resulting conjugates have robust activity against soman-inhibited AChE, and oxime 8b was highlighted as the most efficient one. Although not good as HI-6 in vitro, these new compounds hold promise for development of more efficient centrally acting reactivators for soman poisoning due to their novel nonquaternary structures, which are predicted to be able to cross the blood-brain barrier.

UI MeSH Term Description Entries
D010091 Oximes Compounds that contain the radical R2C Aldoximes,Hydroxyimino Compounds,Ketoxime,Ketoximes,Oxime,Compounds, Hydroxyimino
D011726 Pyridinium Compounds Derivatives of PYRIDINE containing a cation C5H5NH or radical C5H6N. Compounds, Pyridinium
D001812 Blood-Brain Barrier Specialized non-fenestrated tightly-joined ENDOTHELIAL CELLS with TIGHT JUNCTIONS that form a transport barrier for certain substances between the cerebral capillaries and the BRAIN tissue. Brain-Blood Barrier,Hemato-Encephalic Barrier,Barrier, Blood-Brain,Barrier, Brain-Blood,Barrier, Hemato-Encephalic,Barriers, Blood-Brain,Barriers, Brain-Blood,Barriers, Hemato-Encephalic,Blood Brain Barrier,Blood-Brain Barriers,Brain Blood Barrier,Brain-Blood Barriers,Hemato Encephalic Barrier,Hemato-Encephalic Barriers
D002800 Cholinesterase Inhibitors Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. Acetylcholinesterase Inhibitor,Acetylcholinesterase Inhibitors,Anti-Cholinesterase,Anticholinesterase,Anticholinesterase Agent,Anticholinesterase Agents,Anticholinesterase Drug,Cholinesterase Inhibitor,Anti-Cholinesterases,Anticholinesterase Drugs,Anticholinesterases,Cholinesterase Inhibitors, Irreversible,Cholinesterase Inhibitors, Reversible,Agent, Anticholinesterase,Agents, Anticholinesterase,Anti Cholinesterase,Anti Cholinesterases,Drug, Anticholinesterase,Drugs, Anticholinesterase,Inhibitor, Acetylcholinesterase,Inhibitor, Cholinesterase,Inhibitors, Acetylcholinesterase,Inhibitors, Cholinesterase,Inhibitors, Irreversible Cholinesterase,Inhibitors, Reversible Cholinesterase,Irreversible Cholinesterase Inhibitors,Reversible Cholinesterase Inhibitors
D002801 Cholinesterase Reactivators Drugs used to reverse the inactivation of cholinesterase caused by organophosphates or sulfonates. They are an important component of therapy in agricultural, industrial, and military poisonings by organophosphates and sulfonates. Insecticides, Organophosphate, Antagonists,Insecticides, Organothiophosphate, Antagonists,Organophosphate Insecticide Antagonists,Organothiophosphate Insecticide Antagonists,Antagonists, Organophosphate Insecticide,Antagonists, Organothiophosphate Insecticide,Insecticide Antagonists, Organophosphate,Insecticide Antagonists, Organothiophosphate,Reactivators, Cholinesterase
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012999 Soman An organophosphorus compound that inhibits cholinesterase. It causes seizures and has been used as a chemical warfare agent. Pinacolyl Methylphosphonofluoridate,Methylphosphonofluoridate, Pinacolyl

Related Publications

Zhao Wei, and Yan-Qin Liu, and Yong-An Wang, and Wan-Hua Li, and Xin-Bo Zhou, and Jian Zhao, and Chun-Qian Huang, and Xing-Zhou Li, and Jia Liu, and Zhi-Bing Zheng, and Song Li
April 2014, Bioorganic & medicinal chemistry letters,
Zhao Wei, and Yan-Qin Liu, and Yong-An Wang, and Wan-Hua Li, and Xin-Bo Zhou, and Jian Zhao, and Chun-Qian Huang, and Xing-Zhou Li, and Jia Liu, and Zhi-Bing Zheng, and Song Li
January 2012, Journal of medicinal chemistry,
Zhao Wei, and Yan-Qin Liu, and Yong-An Wang, and Wan-Hua Li, and Xin-Bo Zhou, and Jian Zhao, and Chun-Qian Huang, and Xing-Zhou Li, and Jia Liu, and Zhi-Bing Zheng, and Song Li
July 2020, Bioorganic chemistry,
Zhao Wei, and Yan-Qin Liu, and Yong-An Wang, and Wan-Hua Li, and Xin-Bo Zhou, and Jian Zhao, and Chun-Qian Huang, and Xing-Zhou Li, and Jia Liu, and Zhi-Bing Zheng, and Song Li
October 1981, Journal of medicinal chemistry,
Zhao Wei, and Yan-Qin Liu, and Yong-An Wang, and Wan-Hua Li, and Xin-Bo Zhou, and Jian Zhao, and Chun-Qian Huang, and Xing-Zhou Li, and Jia Liu, and Zhi-Bing Zheng, and Song Li
September 2018, Journal of medicinal chemistry,
Zhao Wei, and Yan-Qin Liu, and Yong-An Wang, and Wan-Hua Li, and Xin-Bo Zhou, and Jian Zhao, and Chun-Qian Huang, and Xing-Zhou Li, and Jia Liu, and Zhi-Bing Zheng, and Song Li
August 1985, Biochimica et biophysica acta,
Zhao Wei, and Yan-Qin Liu, and Yong-An Wang, and Wan-Hua Li, and Xin-Bo Zhou, and Jian Zhao, and Chun-Qian Huang, and Xing-Zhou Li, and Jia Liu, and Zhi-Bing Zheng, and Song Li
August 2010, International journal of molecular sciences,
Zhao Wei, and Yan-Qin Liu, and Yong-An Wang, and Wan-Hua Li, and Xin-Bo Zhou, and Jian Zhao, and Chun-Qian Huang, and Xing-Zhou Li, and Jia Liu, and Zhi-Bing Zheng, and Song Li
December 1990, Biochemical pharmacology,
Zhao Wei, and Yan-Qin Liu, and Yong-An Wang, and Wan-Hua Li, and Xin-Bo Zhou, and Jian Zhao, and Chun-Qian Huang, and Xing-Zhou Li, and Jia Liu, and Zhi-Bing Zheng, and Song Li
December 2018, Bioorganic & medicinal chemistry letters,
Zhao Wei, and Yan-Qin Liu, and Yong-An Wang, and Wan-Hua Li, and Xin-Bo Zhou, and Jian Zhao, and Chun-Qian Huang, and Xing-Zhou Li, and Jia Liu, and Zhi-Bing Zheng, and Song Li
February 2007, Neurotoxicity research,
Copied contents to your clipboard!